• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Medical Services International Completes Additional Registrations

Posted on: Tuesday, 5 July 2005, 09:01 CDT

EDMONTON, Alberta, July 5 /PRNewswire-FirstCall/ -- Medical Services International Inc. is pleased to announce that it has received regulatory approval of its VScan Hepatitis C, Tuberculosis (TB) and Syphilis rapid test kits in Ukraine. The company had previously announced approval of its HIV test kit in Ukraine. There is a serious Tuberculosis problem in this part of the world and the fact that there is a rapid test kit for TB that is as accurate as the VScan TB test kit and gives no false positives will be extremely helpful to medical personnel in treating this disease. Tuberculosis is treatable with early diagnosis.

The Company is in the process of registering all four test kits in other countries in the general area. The Company is working with its distributor for the area to develop a comprehensive marketing program. The Company expects to receive an initial order in excess of 50,000 kits within the next 30 days.

About VScan

The VScan test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ .

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.

Medical Services International Inc.

Medical Services International Inc.

CONTACT: Robert Talbot, +1-780-430-6363, or Bill Whitehead, Jr.,+1-416-822-5883, both of Medical Services International Inc.

Web site: http://www.medicalservicesintl.com/http://www.minerva-biotech.com/

Source: PRNewswire-FirstCall

More News in this Category